Screening, Evidence and Safe Prescribing
Use test performance, evidence hierarchy and medicine-quality principles safely.
How to prepare for MRCOG Part 1
Build mechanisms first, then apply anatomy, physiology, pathology, pharmacology, evidence and data interpretation to obstetric and gynaecological decisions.
Core concepts
Concept 1
Screening, sensitivity, specificity, predictive value, evidence levels, risk, quality control and prescribing safety.
Exam cue: Name the Knowledge Area and the scientific mechanism before reviewing the options.
Concept 2
Use population prevalence, test characteristics, benefits and harms to judge whether screening or treatment is justified.
Exam cue: Use gestation, life stage, anatomy, timing and trend to distinguish plausible answers.
Concept 3
Check contraindications, interactions, monitoring, pregnancy exposure and systems that reduce prescribing error.
Exam cue: Choose the safest evidence-based answer that fits the exact point in the clinical pathway.
Concept 4
Connect anatomy, physiology, pathology, pharmacology and evidence to clinical obstetrics and gynaecology rather than revising each science in isolation.
Risk pitfalls and guardrails
Applying a test characteristic or relative effect without population, baseline risk, denominator or medicine context.
Guardrail: Do not select an isolated fact when the SBA asks for the scientific explanation or clinical consequence that best fits the whole stem.
Recalling a basic-science fact without applying it to the obstetric or gynaecological context.
Guardrail: Do not select an isolated fact when the SBA asks for the scientific explanation or clinical consequence that best fits the whole stem.
Inventing a paper-specific or module-specific weighting that RCOG has not published.
Guardrail: RCOG publishes no numerical module weights or Paper 1 versus Paper 2 syllabus allocation; revise the complete map.
Memory anchors
Screening, Evidence and Safe Prescribing: scope
Screening, sensitivity, specificity, predictive value, evidence levels, risk, quality control and prescribing safety.
Screening, Evidence and Safe Prescribing: applied-science lens
Use population prevalence, test characteristics, benefits and harms to judge whether screening or treatment is justified.
Screening, Evidence and Safe Prescribing: safety boundary
Check contraindications, interactions, monitoring, pregnancy exposure and systems that reduce prescribing error.
Screening, Evidence and Safe Prescribing: common trap
Applying a test characteristic or relative effect without population, baseline risk, denominator or medicine context.
Screening, Evidence and Safe Prescribing: Part 1 sequence
Identify the mechanism, connect it to the clinical finding or investigation, check the safety boundary, then choose the single best answer.
Checkpoint rule
Do the check-up only after you can summarize each concept in one sentence and identify one dangerous pitfall from memory.
Knowledge Check (after reading)
Short check-up to confirm understanding of this module.
Check-up Questions
A disease becomes rarer while test sensitivity and specificity stay constant. What usually happens to positive predictive value?
Among 100 positive tests, 80 people truly have disease. What is the positive predictive value?
Answer all questions to submit.
Next step personalized recommendations
Continue learning
Move forward only after this module is stable.
What is Pass Harbor?
Completely free exam prep for 247 UK exams.
- Practice questions
- Flashcards
- Study guides
- Mock exams
- No registration
- No paywall
- Start instantly
“No more expensive exam prep. Quality study tools should be accessible to everyone.”